Delivery Order SPE2DB20D3103-SPE2DB24FP4X8

Award Date 7/11/24
Potential Completion Date 8/1/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,997.21 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564287146 - PROMACTA 25 MG TABLET UU 30S. This contract has a firm fixed price, with an ultimate completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,242.58 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of PROMACTA 50 MG TABLET (National Drug Code 4565046823) and has a completion date of July 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,242.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROMACTA 50 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $11,991.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract provides for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through April 15, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $7,997.74 order is for the supply of PROMACTA 25 MG SUSPENSION PCKT 30S, a specialty pharmaceutical product, with a completion date of February 28, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide the medication PROMACTA 50 MG TABLET UU 30S. The order has a potential value of $7,242.58 and a completion date of February 26, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,242.58 firm fixed-price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product, to support various government healthcare programs. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $7,242.58, is for the delivery of PROMACTA 50 MG TABLET prescription medication to support military treatment programs and facilities. The contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is...
The Defense Logistics Agency (DLA) has awarded a $7,994.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the provision of PROMACTA 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,251.75 firm-fixed-price delivery order is for the supply of PROMACTA 12.5 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4X8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $7,242.58 for the supply of PROMACTA 50 MG TABLET UU 30S. This contract has a firm fixed price and an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/10/24, 9:27 AM